News & Views

8th August 2019

Active Care Group nominated for CMSUK award and recognised by The Royal College of Nursing

It’s been a positive start to the month for the Active Care Group. Two companies within the portfolio have been nominated for several categories at the Case Management Society UK (CSMUK) awards, which take place in London on Friday 13th September.

CMSUK is part of a global organisation of registered Case Managers who are committed to delivering quality case management and adhering to best practice for individuals with spinal cord and acquired brain injuries. Neural Pathways has been nominated for Therapeutic Service Provider of the Year and Anglia Case Management has been nominated for, Therapeutic Service Provider of the Year and Case Management Company of the Year. Anglia’s Joanne Forrest has also been nominated for Case Manager of the Year.

The Royal College of Nursing have also published an online video highlighting examples of good practice at Lane Fox Remeo Respiratory Centre (Remeo) which provides specialist care for individuals with complex respiratory requirements. A link to the video can be accessed via the Remeo website at:

Montreux Capital Management CEO, Oliver Harris, said: “Recognition from The RCN and CMSUK is a great compliment for the Active Care Group, reflecting the hard work of the entire team. Delivering excellent care is at the core of the business, it is always good to see this recognised.”





The information on this site is intended only for the use of Independent Financial Advisors (IFAs) and other professionally recognised financial intermediaries & institutions.. Should you proceed to access this site, you will be representing and warranting that you are an IFA or other professionally recognised financial intermediary . What follows is not an offer or invitation to acquire an investment and should therefore not be relied upon by, any person in any jurisdiction where such an offer or invitation would be unlawful. Persons in respect of whom such prohibitions apply must not access this web site. None of the information contained on this site constitutes personal recommendations nor advice. Product details should always be read in conjunction with the appropriate offering documents. An application for any of the investment products on this page should be made having fully read not only the relevant application form, but also the relevant terms and conditions and offering documents. If you are unsure about the meaning of any information provided on this web page, then please consult your financial or other professional adviser. We do not offer investment advice.

This web site may contain or be linked to advice or statements of third parties. We make no representation as to the accuracy, completeness, timeliness or suitability of such information, and we have not and will not review or update such information and caution you that any use made of such information is at your own risk. Some of the information contained on this web site may also have been prepared or provided by third parties and may not have been verified by us. We hereby exclude any liability arising out of any preparation or provision of such information for the web site and makes no warranty as to the accuracy, suitability or completeness of any such information.

I agree, Continue

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together "the Sponsors," or "Sponsor) do not provide specific individual advice on the suitability of investments with regard to a potential investor's individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

I agree, Continue